Amorphous selenium inhibits oxidative stress injury of neurons in vascular dementia rats by activating NMDAR pathway

Mo-Li Zhu,Jie Zhang,Li-Juan Guo,Rui-Zhu Yue,Shan-Shan Li,Bao-Yue Cui,Shuang Guo,Qian-Qian Niu,Ya-Nan Yu,Huan-Huan Wang,Lin Yang,Ya-Ling Yin,Shuang-Xi Wang,He-Qin Zhan,Zhi-Tao Gao,Peng Li,Mo-li Zhu,Li-juan Guo,Rui-zhu Yue,Shan-shan Li,Bao-yue Cui,Qian-qian Niu,Ya-nan Yu,Huan-huan Wang,Ya-ling Yin,Shuang-xi Wang,He-qin Zhan,Zhi-tao Gao
DOI: https://doi.org/10.1016/j.ejphar.2023.175874
IF: 5.195
2023-09-01
European Journal of Pharmacology
Abstract:Vascular dementia (VD) is one of the most common causes of dementia, taking account for about 20% of all cases. Although studies have found that selenium supplementation can improve the cognitive ability of Alzheimer's patients, there is currently no research on the cognitive impairment caused by VD. This study aimed to investigate the role and mechanism of Amorphous selenium nanodots (A SeNDs) in the prevention of VD. The bilateral common carotid artery occlusion (BCCAO) method was used to establish a VD model. The neuroprotective effect of A SeNDs was evaluated by Morris water maze, Transcranial Doppler TCD, hematoxylin-eosin (HE) staining, Neuron-specific nuclear protein (Neu N) staining and Golgi staining. Detect the expression levels of oxidative stress and Calcium-calmodulin dependent protein kinase II (CaMK II), N-methyl-D-aspartate receptor subunit NR2A, and postsynaptic dense protein 95 (PSD95). Finally, measure the concentration of calcium ions in neuronal cells. The results showed that A SeNDs could significantly improve the learning and memory ability of VD rats, restore the posterior arterial blood flow of the brain, improve the neuronal morphology and dendritic remodeling of pyramidal cells in hippocampal CA1 area, reduce the level of oxidative stress in VD rats, increase the expression of NR2A, PSD95, CaMK II proteins and reduce intracellular calcium ion concentration, but the addition of selective NR2A antagonist NVP-AAMO77 eliminated these benefits. It suggests that A SeNDs may improve cognitive dysfunction in vascular dementia rats by regulating the NMDAR pathway.
pharmacology & pharmacy
What problem does this paper attempt to address?